ZA201804322B - Deep sequencing profiling of tumors - Google Patents

Deep sequencing profiling of tumors

Info

Publication number
ZA201804322B
ZA201804322B ZA2018/04322A ZA201804322A ZA201804322B ZA 201804322 B ZA201804322 B ZA 201804322B ZA 2018/04322 A ZA2018/04322 A ZA 2018/04322A ZA 201804322 A ZA201804322 A ZA 201804322A ZA 201804322 B ZA201804322 B ZA 201804322B
Authority
ZA
South Africa
Prior art keywords
tumors
deep sequencing
profiling
sequencing profiling
deep
Prior art date
Application number
ZA2018/04322A
Other languages
English (en)
Inventor
Nelson Alexander
Daniel Burgess
Stacey Stanislaw
Heidi Rosenbaum
Original Assignee
Ventana Med Syst Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventana Med Syst Inc, Hoffmann La Roche filed Critical Ventana Med Syst Inc
Publication of ZA201804322B publication Critical patent/ZA201804322B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/146Concentration of target or template
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113PCR

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Prostheses (AREA)
ZA2018/04322A 2016-01-15 2018-06-27 Deep sequencing profiling of tumors ZA201804322B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662279126P 2016-01-15 2016-01-15
US201662415952P 2016-11-01 2016-11-01
PCT/US2016/060835 WO2017123316A1 (en) 2016-01-15 2016-11-07 Deep sequencing profiling of tumors

Publications (1)

Publication Number Publication Date
ZA201804322B true ZA201804322B (en) 2022-10-26

Family

ID=57396824

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/04322A ZA201804322B (en) 2016-01-15 2018-06-27 Deep sequencing profiling of tumors

Country Status (12)

Country Link
US (2) US11649492B2 (enExample)
EP (1) EP3402896B1 (enExample)
JP (2) JP7232643B2 (enExample)
KR (1) KR102398465B1 (enExample)
CN (1) CN108463559A (enExample)
AU (1) AU2016386032B2 (enExample)
CA (1) CA3011342C (enExample)
IL (1) IL260304B2 (enExample)
SA (1) SA518392005B1 (enExample)
SG (1) SG11201805600VA (enExample)
WO (1) WO2017123316A1 (enExample)
ZA (1) ZA201804322B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3246416T3 (da) 2011-04-15 2024-09-02 Univ Johns Hopkins Sikkert sekventeringssystem
ES2886507T5 (es) 2012-10-29 2024-11-15 Univ Johns Hopkins Prueba de Papanicolaou para cánceres de ovario y de endometrio
WO2017027653A1 (en) 2015-08-11 2017-02-16 The Johns Hopkins University Assaying ovarian cyst fluid
AU2016386032B2 (en) * 2016-01-15 2021-08-12 F. Hoffmann-La Roche Ag Deep sequencing profiling of tumors
CN111868260B (zh) 2017-08-07 2025-02-21 约翰斯霍普金斯大学 用于评估和治疗癌症的方法和材料
US20200004928A1 (en) 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
CN109234356B (zh) * 2018-09-18 2021-10-08 南京迪康金诺生物技术有限公司 一种构建杂交捕获测序文库的方法及应用
WO2020112566A1 (en) 2018-11-29 2020-06-04 Ventana Medical Systems, Inc. Personalized ctdna disease monitoring via representative dna sequencing
CN113228190B (zh) 2018-12-23 2024-06-11 豪夫迈·罗氏有限公司 分类和/或鉴定癌症亚型的系统和方法
EP3984037A1 (en) 2019-06-13 2022-04-20 F. Hoffmann-La Roche AG Systems and methods with improved user interface for interpreting and visualizing longitudinal data
CN115516108A (zh) 2020-02-14 2022-12-23 约翰斯霍普金斯大学 评估核酸的方法和材料
JPWO2022244856A1 (enExample) 2021-05-20 2022-11-24

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000159A (en) 1974-06-28 1976-12-28 Phillips Petroleum Company Preparation of n,n-disubstituted thioamides
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5176995A (en) 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
WO2006066071A2 (en) * 2004-12-17 2006-06-22 Mayo Foundation For Medical Education And Research Prognosis of renal cell carcinoma
WO2009061840A1 (en) * 2007-11-05 2009-05-14 Complete Genomics, Inc. Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation
CA2707901C (en) * 2007-12-05 2015-09-15 Complete Genomics, Inc. Efficient base determination in sequencing reactions
US8592150B2 (en) * 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
WO2009099602A1 (en) * 2008-02-04 2009-08-13 Massachusetts Institute Of Technology Selection of nucleic acids by solution hybridization to oligonucleotide baits
JP5757572B2 (ja) * 2009-07-03 2015-07-29 国立大学法人 東京大学 癌細胞の存否を判定する方法および癌患者の予後を判定する方法
EP3072968A1 (en) 2010-02-25 2016-09-28 Advanced Liquid Logic, Inc. Method of making nucleic acid libraries
WO2012024658A2 (en) 2010-08-20 2012-02-23 IntegenX, Inc. Integrated analysis system
KR20190002733A (ko) * 2010-12-30 2019-01-08 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화
GB2497510A (en) 2011-11-10 2013-06-19 Harry Cuppens Methods for determining mononucleotide sequence repeats
WO2014106076A2 (en) 2012-12-28 2014-07-03 Quest Diagnostics Investments Incorporated Universal sanger sequencing from next-gen sequencing amplicons
EP2971122B1 (en) * 2013-03-15 2020-08-26 Memorial Sloan Kettering Cancer Center Biomarkers for response to rapamycin analogs
US20140278461A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center System and method for integrating a medical sequencing apparatus and laboratory system into a medical facility
WO2015058093A1 (en) 2013-10-18 2015-04-23 Seven Bridges Genomics Inc. Methods and systems for genotyping genetic samples
US10415083B2 (en) 2013-10-28 2019-09-17 The Translational Genomics Research Institute Long insert-based whole genome sequencing
AU2016386032B2 (en) 2016-01-15 2021-08-12 F. Hoffmann-La Roche Ag Deep sequencing profiling of tumors

Also Published As

Publication number Publication date
IL260304B1 (en) 2024-12-01
WO2017123316A1 (en) 2017-07-20
SA518392005B1 (ar) 2022-02-08
CA3011342A1 (en) 2017-07-20
JP2021176302A (ja) 2021-11-11
IL260304A (en) 2018-08-30
CA3011342C (en) 2023-03-14
JP7232643B2 (ja) 2023-03-03
JP7379418B2 (ja) 2023-11-14
KR102398465B1 (ko) 2022-05-13
EP3402896B1 (en) 2021-03-31
SG11201805600VA (en) 2018-07-30
US20180320229A1 (en) 2018-11-08
IL260304B2 (en) 2025-04-01
KR20180098412A (ko) 2018-09-03
BR112018014349A2 (pt) 2019-02-12
AU2016386032B2 (en) 2021-08-12
JP2019503182A (ja) 2019-02-07
AU2016386032A1 (en) 2018-07-12
EP3402896A1 (en) 2018-11-21
US11649492B2 (en) 2023-05-16
US20230250476A1 (en) 2023-08-10
CN108463559A (zh) 2018-08-28

Similar Documents

Publication Publication Date Title
ZA201804322B (en) Deep sequencing profiling of tumors
IL296080B1 (en) Method for treating cancer
IL269026A (en) Methods of treating tumor
IL259783A (en) Methods of treatment of malignant diseases
ZA201804227B (en) Methods of treating cancer
IL255189A0 (en) Cancer treatment methods
IL250677A0 (en) Cancer treatment using anti-nkg2a agents
DK3240801T3 (da) Kombinationstumorimmunterapi
PL3283527T3 (pl) Leczenie skojarzone nowotworów
IL262342A (en) Cancer treatment methods
GB201410646D0 (en) Methods of increasing sequencing accuracy
EP3310915A4 (en) TUMOR IMMUNOTHERAPY
SG10201913528PA (en) Methods of diagnosing cancer
GB201602210D0 (en) Detection of cancer
EP3534952A4 (en) BI-SPECIFIC ACTIVATORS FOR ANTI-TUMOR THERAPY
GB201408297D0 (en) Treatment of cancer
KR20180084983A (ko) 암의 치료를 위한 피리미도-피리미다지논의 용도
GB201512678D0 (en) Methods of chemical synthesis
DK3277813T3 (da) Hidtil ukendt terapi
IL247270B (en) A method for detecting cancer
GB201407837D0 (en) Methods of cancer therapy
GB201417456D0 (en) Treatment of cancer
SG10201603579PA (en) Methods Of Detecting Cancer
GB201604600D0 (en) Determination of relative sensitivities
GB201508443D0 (en) Methods of identifying USP-binding compounds